Loading...
menu
Search
AI Trading Bot
Features
Markets
News
Resources
Pricing
Get Started
Home
ETF
RVMD
RVMD
-
Add to Watchlist
$
0.000
0.000
(
0.000%
)
At close
0.000
(
0.000%
)
Aft-market
ET
$
0.000
0.000
(
0.000%
)
At close
0.000
(
0.000%
)
Aft-market
ET
Overview
Technical
News
RVMD News
Revolution Medicines' Pancreatic Cancer Therapy Nears Approval
Jun 11 2026
NASDAQ.COM
Revolution Medicines Achieves Breakthrough with New Drug for Pancreatic Cancer
Jun 11 2026
Fool
Tango Therapeutics Raises Drug Sales Estimate to $2.6 Billion
Jun 08 2026
stocktwits
Tango Therapeutics Shares Surge 32% on Promising Trial Data for Vopimetostat
Jun 08 2026
seekingalpha
Revolution Medicines Achieves Strong Phase 3 Clinical Trial Results
Jun 05 2026
NASDAQ.COM
Revolution Medicines Stock Soars 285% Amid Clinical Progress
Jun 05 2026
Fool
Biotech Firms Shift to Nanotechnology-Driven Drug Delivery
Jun 03 2026
Globenewswire
Biotech Companies Focus on Drug Delivery Technologies
Jun 03 2026
Newsfilter
Investors Eye Economic Data and Earnings Reports
Jun 01 2026
stocktwits
Revolution Medicines Reports Phase 3 Results for Daraxonrasib
Jun 01 2026
NASDAQ.COM
Daraxonrasib Significantly Improves Pancreatic Cancer Survival Rates
Jun 01 2026
stocktwits
Revolution Medicines' Cancer Drug Trial Shows Promising Results
May 31 2026
seekingalpha
Revolution Medicines Reports Daraxonrasib Clinical Trial Results
May 31 2026
Newsfilter
Goldman Sachs' Hedge Fund VIP List Includes Micron Technology
May 27 2026
CNBC
Biotech Fund Sells Erasca Stake After 700% Rally
May 18 2026
Yahoo Finance
Boxer Capital Acquires $17.55 Million Stake in Corvus Pharmaceuticals
May 17 2026
Yahoo Finance
Show More News
